. 2018 Mar 29;18(1):112–123. doi: 10.1007/s12663-018-1106-3

Table 1.

Patient data

Sr. no.	Patient	Age	Sex	Chief complaint	Final diagnosis	Site	Size (mm.)	Quantity of BFP extracted (gm)	Cell culture period (days)	Number of BFPSCs obtained (in millions/ml)	Mean bone density (% voxels)		Gain in mean bone density (% voxels)	Cell surface markers assessed	Postoperative complications
Sr. no.	Patient	Age	Sex	Chief complaint	Final diagnosis	Site	Size (mm.)	Quantity of BFP extracted (gm)	Cell culture period (days)	Number of BFPSCs obtained (in millions/ml)	Preoperative	Postoperative 6 months	Gain in mean bone density (% voxels)	Cell surface markers assessed	Postoperative complications
1.	A	55	F	Painful swelling	Type 1 unicystic ameloblastoma	Left maxilla	35X45	2.58	63	3.5	14	88	74	CD 9, 10, 13, 29, 34, 45, 49d, 90, 105, 106, 146, HLA-ABC, HLA-DR. ALP, OCN	Pain at 1 month, none later
2.	B	50	F	Swelling	Keratocystic odontogenic tumor	Right mandible, body region	25X45	3.17	35	3.8	18	86	68	CD 9, 10, 13, 29, 34, 45, 49d, 90, 105, 106, 146, HLA-ABC, HLA-DR. ALP, OCN	None
3.	C	38	M	Facial deformity	Keratocystic odontogenic tumor	Left mandible, angle-ramus region	45X55	3.2	45	4.1	12	92	80	CD 9, 10, 13, 29, 34, 45, 49d, 90, 105, 106, 146, HLA-ABC, HLA-DR. ALP, OCN	Paresthesia at 1 month, none later
4.	D	28	F	Pain	Radicular cyst	Right mandible, body region	25X35	2.32	33	5.8	15	88	73	CD 10, 13, 29, 34, 45, 49d, 90, 105, 106, 146, HLA-ABC, HLA-DR. ALP, OCN	None
5.	E	44	M	Pain	Type 1 unicystic ameloblastoma	Left mandible, body, angle region	30X20	3.16	37	5.2	16	90	74	CD 9, 10, 13, 29, 34, 45, 49d, 90, 105, 106, 146, HLA-ABC, HLA-DR. ALP, OCN	None